Financials
- Market Capitalization 15.47 M
- Employee 6
- Founded 2009
- CEO N/A
- Website www.kalarx.com
- Headquarter Delaware, United States
- FIGI BBG001J2MVT8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.17
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4651 | TPST Tempest Therapeutics, Inc. - Common Stock | 1.08 USD | 0.00% | +6.93% | +27.06% | -54.81% | 15.99 M USD | ||
| 4662 | HIND Vyome Holdings, Inc. - Common Stock | 2.21 USD | +2.79% | 0.00% | +11.06% | -76.39% | 15.51 M USD | ||
| 4671 | ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.69 USD | -4.21% | -4.37% | +98.26% | +1358.97% | 14.94 M USD | ||
| 4682 | AEON AEON Biopharma, Inc. Class A Common Stock | 0.29 USD | +16.00% | +45.00% | +11.54% | -72.12% | 14.47 M USD |